Hot Products

16 alpha-Hydroxytrametenolic acid
Catalog No: CFN90803

16 alpha-Hydroxytrametenolic acid can inhibit 12-O-tetradecanoylphorbol 13-acetate (TAP)-induced mouse ear edema.
16-Oxoalisol A
Catalog No: CFN92547

Reference standards.
17alpha-Neriifolin
Catalog No: CFN97195

17alpha-Neriifolin and 17alpha-Deacetyltanghinin have little anti-proliferative activity, indicating that the 17beta configuration is critical for the anti-proliferative activity of these compounds.
19,20-(E)-Vallesamine
Catalog No: CFN98432

Reference standards.
1-Acetyl-beta-carboline
Catalog No: CFN92122

Combination of 1-acetyl-beta-carboline with ampicillin exhibits synergistic antibacterial activity against MRSA.
1beta-Hydroxyalantolactone
Catalog No: CFN92600

1beta-Hydroxyalantolactone has protective effect against AD-like skin inflammation, can as a potential therapeutic agent for AD.
1-Caffeoylquinic acid
Catalog No: CFN99121

1-Caffeoylquinic acid is an important intermediate in lignin biosynthesis. 1-Caffeoylquinic acid has anti-influenza, and antioxidant activities, it also slows the release of glucose into the bloodstream after a meal.
1-Dehydro-10-gingerdione
Catalog No: CFN92374

1-Dehydro-10-gingerdione has anti-inflammatory action, the molecular target is Myeloid differentiation protein; it involves in the suppression of NF-κB-regulated gene expression in LPS-activated macrophages, has therapeutic potential in NF-κB-associated inflammation and autoimmune disorders.
1-Dehydro-6-gingerdione
Catalog No: CFN92298

1-Dehydro-6-gingerdione is a 5-HT1A receptor partial agonist.1-Dehydro-6-gingerdione has antioxidant and anti-inflammatory activities, it significantly suppresses the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) proteins in a concentration-dependent fashion.
1-Deoxynojirimycin
Catalog No: CFN99933

1-Deoxynojirimycin is a potent α-glucosidase inhibitor, suppresses postprandial blood glucose, thereby possibly preventing diabetes mellitus. 1-Deoxynojirimycin as a therapeutic agent by controlling the overgrowth and biofilm formation of S. mutans, it also can block human immunodeficiency virus envelope glycoprotein- mediated membrane fusion at the CXCR4 binding step.